Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients : Relation to disease activity and manifestations

Anticyclic citrullinated protein/ peptide antibody assays in rheumatoid arthritis and correlation with disease severity parameters and radiographic damage

Anti-cyclic citrullinated peptide antibodies in thediagnosis of rheumatoid arthritis:Correlation with some clinical and laboratory data

Anti-nucleosome antibodies and systemic lupus erythematosus

Antibodies to cyclic citrullinated peptide in a groupof patients with rheumatoid and SLE arthritis

Detection of Anti-cyclic citrullinated peptides antibodies in the sera of patients with systemic lupus erythromatosus :Association with clinical and laboratory parameters of the disease

Tumour necrosis factor-alpha in rheumatoid arthritis

Anti-topoisomerase-I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus

Microalbuminuria in patients with rheumatoid arthritis

Serum matrix metalloproteinase-3 in rheumatoid arthritis correlation with disease activity